Carbios Clears Cost Hurdles and Textile Test, but Longlaville Financing Remains the Deciding Vote

Carbios cut its H1 2026 net loss to EUR 9.4 million with EUR 48 million cash, but Longlaville plant financing and a beverage deal remain unsigned.

Carbios has spent the summer proving its enzymatic recycling technology can survive contact with real factory floors. What the French biochemistry group has not yet proven is that it can get its flagship plant financed before its cash cushion wears thin.

That tension sits at the heart of the investment case after the company reported first-half 2026 results on 24 September. Operating expenses fell 19% year-on-year, and the net loss narrowed to EUR 9.4 million from EUR 11.9 million a year earlier. Cash and cash equivalents stood at EUR 48 million as of 30 June 2026 — enough, management says, to fund ongoing operations beyond the next twelve months. The immediate refinancing squeeze on day-to-day business has eased. The bigger cheque, however, is still being written.

Textile Recycling Passes Its Industrial Audition

Before the financing question moved to centre stage, Carbios delivered a technical milestone that had been years in the making. Working alongside the Fiber-to-Fiber consortium — whose members include Patagonia, PUMA and Salomon — the company produced T-shirts from recycled polyester on European industrial equipment.

The resulting EnzyTex polyester, according to the company, matched the properties of virgin polyester derived from fossil feedstocks. In practical terms, Carbios demonstrated that complex waste streams from textiles and plastics can be recovered at industrial scale. It is the kind of validation that matters to brand partners weighing whether to commit to recycled fibre — and to lenders assessing whether the technology underneath Longlaville actually works.

Where the Money Still Has to Come From

Longlaville, the planned plant in northern France, remains the linchpin of Carbios's long-term strategy. On project financing, the company has reported meaningful interim progress: credit committees at a majority of the participating lenders have already approved the proposal. Reviews by export credit agencies and prospective equity partners are still running.

The missing piece is the final signature. Until the debt agreements are formally executed, the company's core project stays in a risky holding pattern — a point investors have clearly registered.

A Beverage Contract That Would Change the Maths

Offsetting that uncertainty is a commercial agreement with a major player in the beverage industry that Carbios says is in the final stages of negotiation. Once signed, the deal would lift pre-sales to 60% of the plant's nominal capacity.

That single number carries outsized weight. It would simultaneously demonstrate genuine market demand for the enzymatic recycling process and give the banks the planning certainty they need to release funds. Combined with the cost reductions already achieved, a completed beverage contract and a closed financing package could mark the transition from research-driven outfit to profitable industrial supplier — and would remove the largest operational unknown in one stroke.

The Clock on the Cash Buffer Is Ticking

Failure to close, or further delay, would hit shareholders hard. Even with lower expenses, a half-year loss above EUR 9.4 million shows Carbios continues to burn liquidity. The EUR 48 million on hand buys time, but not unlimited room for protracted renegotiation. Should individual banks withdraw their commitments or tighten terms, the company could face an acute funding gap — potentially leaving a costly capital raise at current price levels as the only route.

With the stock down 52% since the start of the year, dilution at depressed prices would badly erode existing holdings. Delays in reaching the planned 60% capacity utilisation could also dent confidence in the economics of the technology itself.

What Investors Are Actually Pricing

The market's caution was on display Thursday, when the shares fell 8.9% to close at EUR 5.42. With a market capitalisation of EUR 100.22 million, the valuation already embeds substantial doubt about a smooth execution.

The path forward can be judged against clear markers. As long as the credit committee approvals hold and spending discipline sticks, the chance of a re-rating stays alive. If the timetable for the beverage deal slips or lenders exit the consortium, financing risk escalates abruptly.

Two catalysts will settle the question: official announcement of the beverage offtake contract and formal completion of the Longlaville financing agreements. Only when both milestones are reached does a durable foundation for commercial operations exist.